Business Context and Reporting Period
Simulations Plus, Inc. (SLP) filed a Form 8-K on June 15, 2026, announcing the entry into a definitive Agreement and Plan of Merger. The Company, a California corporation, will merge with SP Evolution BidCo II, LLC, a wholly-owned subsidiary of SP Evolution HoldCo II, LLC (an affiliate of Altaris, LLC). Upon closing, Simulations Plus will become a wholly-owned subsidiary of the Parent entity, and its common stock will be delisted from the Nasdaq Global Select Market.
Key Financial Metrics and Transaction Terms
- Merger Consideration: Shareholders will receive $18.50 in cash per share of common stock, without interest.
- Option Treatment: Outstanding options will vest in full and be converted to cash payments equal to the excess of the $18.50 merger price over the exercise price. Options with exercise prices at or above $18.50 will be cancelled for no consideration.
- Financing: The transaction is not subject to a financing condition. Parent has secured sufficient equity and debt financing commitments from Altaris-affiliated funds to fund the purchase price and related costs.
- Transaction Bonuses: A transaction bonus program totaling approximately $3.114 million has been approved for eligible employees, including Named Executive Officers (NEOs). Specific NEO bonuses include $822,000 for the CEO and $539,000 for the CFO.
- Termination Fees: The Company may be required to pay a $13,000,000 termination fee under specific circumstances (e.g., entering a superior proposal). Parent may be required to pay a $26,000,000 termination fee if it fails to consummate the merger when obligated.
Note: This filing does not provide current revenue, profit, cash flow, margin, debt, or liquidity metrics for Simulations Plus, Inc. Those figures are contained in the Company's periodic reports (10-K/10-Q).
Material Changes and Conditions
The primary material change is the proposed change of control. The transaction is subject to several closing conditions, including:
- Approval by holders of a majority of outstanding Company Common Shares.
- Receipt of required regulatory approvals and the expiration of waiting periods under the Hart-Scott-Rodino Act.
- Absence of any legal restraint prohibiting the merger.
- Accuracy of representations and warranties and absence of a Material Adverse Effect.
The Merger Agreement includes a "no-shop" provision, though the Board retains a fiduciary out to consider superior proposals under specific conditions. The transaction has an "End Date" of February 10, 2027, after which either party may terminate the agreement if the merger has not been consummated.
Outlook, Risks, and Management Commentary
The Board of Directors unanimously determined the transaction is fair and in the best interests of shareholders and has recommended approval. The Company expects to file a proxy statement with the SEC to solicit shareholder votes.
Key Risks and Contingencies:
- Transaction Failure: Risks include failure to obtain shareholder approval, regulatory approvals, or financing (despite commitments), or the occurrence of a Material Adverse Effect.
- Operational Distraction: Management attention may be diverted from ongoing business operations.
- Competing Proposals: Risk of competing acquisition proposals or the need to pay termination fees.
- Market Impact: Potential adverse effects on the market price of common stock and operating results during the pendency of the transaction.
- Regulatory and Legal: Risks related to changes in laws, cybersecurity incidents, and potential litigation regarding the merger.
Investor Verification Checklist
- Verify the final terms of the Merger Agreement in the definitive proxy statement (Schedule 14A) once filed.
- Confirm the exact number of shares outstanding to calculate total transaction value.
- Review the Company's most recent 10-K and 10-Q filings for current financial health, debt levels, and liquidity not detailed in this 8-K.
- Monitor the status of regulatory approvals and the shareholder vote date.
- Assess the impact of the $3.114 million transaction bonus on the Company's cash position prior to closing.
- Check for any updates regarding the "End Date" of February 10, 2027, or potential extensions.